Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Double-blind Crossover Study of Sivopixant (S-600918) in Sleep Apnea Syndrome
jRCT2080225317Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sivopixant in sleep apnea (2 arms), sponsored by Shionogi & Co., Ltd. Primary endpoint: Change in apnea-hypopnea index (AHI) at Day 7 from baseline. Started Aug 2020; status: completed.
02
Drugs
sivopixant
03
Conditions
sleep apnea
Beyond the preview
Go deeper on jRCT2080225317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225317.